Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry. Now that GLP-1s have entered the picture as a quick-acting weight loss solution, there’s an argument to be made that we’re getting farther from the root of the problem: weight loss maintenance.